(Q48186723)

9 February 2018

title

Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis. (English)

1 reference

9 February 2018

0 references

Hamamcioglu K

1

1 reference

9 February 2018

Reder AT

series ordinal

2

1 reference

9 February 2018

publication date

9 February 2007

1 reference

9 February 2018

Multiple Sclerosis Journal

published in

1 reference

9 February 2018

volume

13

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

page(s)

459-470

1 reference

9 February 2018

https://api.crossref.org/works/10.1177%2F1352458506069672

1 reference

Brain-derived neurotrophic factor in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Biological properties of interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Type I interferons inhibit interleukin-10 production in activated human monocytes and stimulate IL-10 in T cells: implications for Th1-mediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

On the horizon: possible neuroprotective role for glatiramer acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

IFN-alpha2b increases interleukin-10 expression in primary activated human CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

B cells regulate autoimmunity by provision of IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Abnormal levels of interferon-gamma receptors in active multiple sclerosis are normalized by IFN-beta therapy: implications for control of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Low T8 antigen density on lymphocytes in active multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Effect of immunomodulatory drugs on in vitro production of brain-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Macrophages and Microglia Produce Local Trophic Gradients That Stimulate Axonal Sprouting Toward but Not beyond the Wound Edge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Defective post-thymic tolerance mechanisms during the chronic progressive stage of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

Interactions between the sympathetic nervous system and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069672

21 January 2018

Identifiers

DOI

10.1177/1352458506069672

1 reference

9 February 2018

PubMed ID

17463069

1 reference

9 February 2018